コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ted from both datasets, with varying sets of common variables.
4 egration by evaluating the impact of varying common variables during statistical matching and explori
5 cell activation, and convey to patients with common variable immune deficiency (CVID) an increased ri
12 ICOSL, or SH2D1, and are best classified as common variable immune deficiency (CVID), although other
16 Sensitivity analyses removing patients with common variable immune deficiency and their matched tran
17 mortality statistics from 473 subjects with common variable immune deficiency followed over 4 decade
19 cy has been reported as a monogenic cause of common variable immune deficiency with features of immun
20 tivator and CAML interactor (TACI) result in common variable immune deficiency, a syndrome marked by
21 mechanism explaining the primary features of common variable immune deficiency, exquisite vulnerabili
22 ther disorders, including Evans syndrome and common variable immune deficiency, have been found to ha
24 ed immunodeficiency syndrome (AIDS); one had common variable immune deficiency; and 18 were receiving
25 frequent cause of morbidity and mortality in common variable immunodeficiencies (CVIDs); however, lun
27 ound that 4 of 19 unrelated individuals with common variable immunodeficiency (CVID) and 1 of 16 indi
29 rial translocation is a shared phenomenon in common variable immunodeficiency (CVID) and X-linked aga
33 ma cells, and almost 10% of individuals with common variable immunodeficiency (CVID) express either t
34 gG antibodies in a subgroup of patients with common variable immunodeficiency (CVID) following messen
60 e genetic causes of immune deficiency in 235 common variable immunodeficiency (CVID) patients seen in
61 in patients with autoimmune diseases and in common variable immunodeficiency (CVID) patients who are
65 der, several research groups have identified common variable immunodeficiency (CVID) subjects with nu
67 isotype-switched antibodies in patients with common variable immunodeficiency (CVID) suggests germina
68 the HVR of control patients to patients with common variable immunodeficiency (CVID) where the effect
70 rom 139 patients with PADs, 61 patients with common variable immunodeficiency (CVID), 68 patients wit
71 arisons between patients with GS, those with common variable immunodeficiency (CVID), and those with
72 fe-threatening complication in patients with common variable immunodeficiency (CVID), but the optimal
73 greatest cause of morbidity and mortality in common variable immunodeficiency (CVID), but their patho
75 ts with multilineage cytopenias secondary to common variable immunodeficiency (CVID), Evans syndrome
76 al profile of CD4 T cells from patients with common variable immunodeficiency (CVID), including produ
89 d, multicenter study, 505 patients with IEI (common variable immunodeficiency [CVID], isolated or und
90 was highly similar to that of patients with common variable immunodeficiency and a defect in B-cell
91 ilin ligand interactor (TACI), contribute to common variable immunodeficiency and autoimmunity in hum
92 in SEC61A1 were reported to be pathogenic in common variable immunodeficiency and glomerulocystic kid
93 on, shown through the study of patients with common variable immunodeficiency and hyper IgM syndrome,
94 ustrate the heterogeneous molecular basis of common variable immunodeficiency and indicate the value
95 ar-old woman with a presumptive diagnosis of common variable immunodeficiency and livedo reticularis
96 is review discusses the latest insights into common variable immunodeficiency and uses common variabl
97 everal primary immunodeficiencies, including common variable immunodeficiency and Wiskott-Aldrich syn
99 and additional family members suffering from common variable immunodeficiency and/or selective IgA de
100 to common variable immunodeficiency and uses common variable immunodeficiency as a model to examine t
106 le nucleotide polymorphisms in patients with common variable immunodeficiency disorder (CVID), which
108 mplex polygenic disorders, most commonly the common variable immunodeficiency disorders (CVIDs), pred
112 rmore, mutations in IKZF1 are known to cause common variable immunodeficiency in patients characteriz
116 e defects affect a minority of patients with common variable immunodeficiency only, future genetic re
117 predominantly antibody deficiency other than common variable immunodeficiency or agammaglobulinemia.
118 native classification of patients fulfilling common variable immunodeficiency or Evans syndrome crite
119 some children currently classified as having common variable immunodeficiency or Evans syndrome.
120 tterns in gut biopsies from individuals with common variable immunodeficiency or with HIV infection a
121 Using these assays, we could categorize common variable immunodeficiency patients into subgroups
122 children <2 y, the asplenic, and a subset of common variable immunodeficiency patients, are profoundl
123 rated IRF4 to be deregulated in B cells from common variable immunodeficiency patients, contributing
127 tic assessment in paediatric patients with a common variable immunodeficiency phenotype, to establish
131 Newly identified disease genes within the common variable immunodeficiency population, have advanc
133 ith unusually frequent bacterial infections, common variable immunodeficiency should always be consid
134 day period from a poliomyelitis patient with common variable immunodeficiency syndrome (a defect in a
135 ional features not typically associated with common variable immunodeficiency were diagnosed only lat
137 hich was previously implicated as a cause of common variable immunodeficiency with autoimmunity.
140 n a clinical picture that is consistent with common variable immunodeficiency, and as many as 10% of
141 orders such as systemic lupus erythematosus, common variable immunodeficiency, and autoimmune lymphop
142 r other causes of villous atrophy, including common variable immunodeficiency, autoimmune enteropathy
143 gous mutations in NFKB1 were associated with common variable immunodeficiency, however, homozygous mu
144 ysis of the proportion of any combination of common variable immunodeficiency, IgG deficiency, IgA de
145 -telangiectasia, Nijmegen-breakage-syndrome, common variable immunodeficiency, immunoglobulin A defic
146 tion, dedicator of cytokinesis 8 deficiency, common variable immunodeficiency, neutropenia, and immun
147 nostic categories such as ALPS-like disease, common variable immunodeficiency, or Evans syndrome have
148 present the different clinical phenotypes of common variable immunodeficiency, review recent genetic
149 t poliovirus infection in an individual with common variable immunodeficiency, using oral immunoglobu
150 nted with a phenotype resembling early-onset common variable immunodeficiency, while extra-immunologi
151 the diagnosis and treatment of patients with common variable immunodeficiency, with suggestions for t
152 tions in LRBA Biallelic LRBA mutations cause common variable immunodeficiency-8; however, NDM has not
153 s human PRKCD deficiency as a novel cause of common variable immunodeficiency-like B-cell deficiency
167 observation of large differences due to less common variables indicates the complex nature of the for